Effectiveness of the 13-valent pneumococcal conjugate vaccine against medically attended pneumococcal lower respiratory tract infection among older adults: a case–control study

Abstract The 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for more than a decade for older adults and individuals with chronic medical or immunocompromising conditions. However, real-world evidence on its vaccine effectiveness (VE) in this population especially Low- or Middl...

Descripció completa

Dades bibliogràfiques

Autors principals:	Thundon Ngamprasertchai, Phatharajit Phatharodom, Kaewta Intalapaporn, Kamolawat Sutthipool, Piriyaporn Chongtrakool, Thitiya Yungyuen, Viravarn Luvira, Winai Ratanasuwan, Pinyo Rattanaumpawan, Saranath Lawpoolsri, Punnee Pitisuttithum
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-11-01
Col·lecció:	Scientific Reports
Matèries:	Vaccine effectiveness Pneumococcal conjugate vaccine PCV13 Lower respiratory tract infection Older adults
Accés en línia:	https://doi.org/10.1038/s41598-025-24784-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!